Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Resistant Prostatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02814669
What this trial is testing

Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor

Who this might be right for
Castrate-Resistant Prostate Cancer
Hoffmann-La Roche 45
Testing effectiveness (Phase 2)Study completedNCT04381832
What this trial is testing

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantAndrogen-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms+1 more
Arcus Biosciences, Inc. 173
Early research (Phase 1)Active Not RecruitingNCT04662580
What this trial is testing

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 183
Not applicableUnknownNCT03177551
What this trial is testing

Predictive Nomogram of CRPC

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Tianjin Medical University Second Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01309672
What this trial is testing

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 41
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Early research (Phase 1)Ended earlyNCT03150056
What this trial is testing

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 73
Testing effectiveness (Phase 2)Study completedNCT01174368
What this trial is testing

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Who this might be right for
Prostate Cancer
The Rogosin Institute 1
Early research (Phase 1)Ended earlyNCT04677855
What this trial is testing

Study of PCUR-101 in Combination With ADT in Patients With mCRPC

Who this might be right for
Prostate Cancer
Pellficure Pharmaceuticals, Inc 7
Testing effectiveness (Phase 2)Study completedNCT01498978
What this trial is testing

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 10
Testing effectiveness (Phase 2)WithdrawnNCT01368003
What this trial is testing

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Who this might be right for
Adenocarcinoma of the Prostate
Toni Choueiri, MD
Testing effectiveness (Phase 2)UnknownNCT05156424
What this trial is testing

A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer

Who this might be right for
ExerciseProstate Cancer
Kira Murphy 24
Early research (Phase 1)Looking for participantsNCT06705686
What this trial is testing

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma
TechnoGenesys, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT04704505
What this trial is testing

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Large-scale testing (Phase 3)WithdrawnNCT03800784
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableUnknownNCT04126915
What this trial is testing

Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)

Who this might be right for
Castration-Resistant Prostatic Cancer
Yinghao Sun 200
Testing effectiveness (Phase 2)Study completedNCT00110188
What this trial is testing

Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)

Who this might be right for
Prostate Cancer
Merck Sharp & Dohme LLC 39
Large-scale testing (Phase 3)Ended earlyNCT01981707
What this trial is testing

F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer

Who this might be right for
Castration-resistant Prostate Cancer
University Hospital, Grenoble 12
Testing effectiveness (Phase 2)Ended earlyNCT02640534
What this trial is testing

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Who this might be right for
Cancer of the ProstateProstate Cancer
Swiss Cancer Institute 169
Not applicableUnknownNCT04188275
What this trial is testing

CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

Who this might be right for
D011471D064129D035683+2 more
Azienda Ospedaliero-Universitaria Careggi 46
Next Page